Free Trial

AdvisorShares Psychedelics ETF Rating

AdvisorShares Psychedelics ETF logo
$10.62 +0.12 (+1.14%)
(As of 12/20/2024 05:31 PM ET)

AdvisorShares Psychedelics ETF Aggregate Rating and Price Target (2025)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

PSIL Aggregate Rating

Buy
3.00

Holdings in PSIL have an aggregate rating of Buy based on 103 analyst ratings issued in the past year covering 12 companies (66.1% of the portfolio).

PSIL Aggregate Price Target

$10.62
High Prediction$10.62
Average Prediction$10.62
Low Prediction$10.62

Holdings in PSIL have an aggregate price target of $10.62 and a range of $10.62 to $10.62 covering 12 companies (66.1% of the portfolio).

PSIL Consensus Ratings of Holdings

Strong Buy
1 Strong Buy rating(s)
Buy
6 Buy rating(s)
Moderate Buy
3 Moderate Buy rating(s)
Hold
2 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by AdvisorShares Psychedelics ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 12 PSIL Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
12.25%
Mind Medicine (MindMed) Inc. stock logo
MNMD
Mind Medicine (MindMed)
$7.16
+2.1%
2.9441 of 5 stars
3.25$26.75 273.6%12Analyst Forecast
News Coverage
8.04%
NRx Pharmaceuticals, Inc. stock logo
NRXP
NRx Pharmaceuticals
$1.50
-1.3%
3.3034 of 5 stars
3.33$32.00 2,033.3%3News Coverage
Positive News
6.49%
Atai Life Sciences stock logo
ATAI
Atai Life Sciences
$1.19
1.8886 of 5 stars
3.00$9.00 656.3%4Positive News
High Trading Volume
6.40%
Alkermes plc stock logo
ALKS
Alkermes
$29.71
-0.9%
4.6633 of 5 stars
2.58$35.42 19.2%12Positive News
High Trading Volume
4.90%
Intra-Cellular Therapies, Inc. stock logo
ITCI
Intra-Cellular Therapies
$83.45
-0.8%
4.0584 of 5 stars
2.85$97.23 16.5%13
4.82%
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$135.42
+0.3%
4.8318 of 5 stars
2.83$166.00 22.6%23Analyst Forecast
Insider Trade
High Trading Volume
4.81%
GH Research PLC stock logo
GHRS
GH Research
$6.85
-7.3%
1.1085 of 5 stars
3.00$35.67 420.7%3Positive News
4.56%
Sage Therapeutics, Inc. stock logo
SAGE
Sage Therapeutics
$5.61
+12.2%
4.0569 of 5 stars
2.00$11.53 105.5%20High Trading Volume
4.55%
COMPASS Pathways plc stock logo
CMPS
COMPASS Pathways
$3.97
+1.3%
2.8264 of 5 stars
3.00$33.60 746.3%6Positive News
4.54%
Vistagen Therapeutics, Inc. stock logo
VTGN
Vistagen Therapeutics
$2.50
+11.1%
0.9742 of 5 stars
4.001High Trading Volume
3.49%
Enveric Biosciences, Inc. stock logo
ENVB
Enveric Biosciences
$0.33
-1.0%
2.5245 of 5 stars
3.00$10.00 2,976.9%1Gap Down
1.20%
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
$0.36
+2.9%
4.19 of 5 stars
2.00$4.25 1,071.1%5Gap Down

This page (NYSEARCA:PSIL) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners